Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial.
about
Effective and sustainable biologic treatment of psoriasis: what can we learn from new clinical data?Efficacy of systemic therapies for moderate-to-severe psoriasis: a systematic review and meta-analysis of long-term treatment.Use of biologic agents in combination with other therapies for the treatment of psoriasisEtanercept in the treatment of plaque psoriasisUpdate of the management of chronic psoriasis: new approaches and emerging treatment options.A multicenter, randomized, open-label pilot trial assessing the efficacy and safety of etanercept 50 mg twice weekly followed by etanercept 25 mg twice weekly, the combination of etanercept 25 mg twice weekly and acitretin, and acitretin alone in paLong-term efficacy of biologics in dermatology.A review of acitretin for the treatment of psoriasis.Long term efficacy and safety of etanercept in the treatment of psoriasis and psoriatic arthritisAcitretin revisited in the era of biologics.Efficacy of etanercept for the treatment of psoriasis: an overview of the Italian clinical experience from the real-life setting and independent studies.Combination therapy in psoriasis: an evidence-based review.A consensus report on appropriate treatment optimization and transitioning in the management of moderate-to-severe plaque psoriasis.Efficacy and safety of systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials.Biological therapies for psoriasis.Acitretin in psoriasis: an evolving scenario.An updated survey for the 2007-2013 period of randomized controlled trials for psoriasis: treatment modalities, study designs, comparators, outcome measures and sponsorship.Nuclear retinoid receptors and pregnancy: placental transfer, functions, and pharmacological aspects.Etanercept, improved dosage schedules and combinations in the treatment of psoriasis: an update.A dermatologist guide to immunogenicityBiologics combined with conventional systemic agents or phototherapy for the treatment of psoriasis: real-life data from PSONET registries.Psoriasis in Solid Organ Transplant Patients: Best Practice Recommendations from the Medical Board of the National Psoriasis Foundation.Algorithm to select optimal systemic anti-psoriatic drugs in relation with patients' Psoriasis Area and Severity Index score for plaque psoriasis.Low-dose methotrexate - a therapeutical kick in TNF-alpha antagonist treatment for recalcitrant psoriasis vulgaris.Refractory generalized pustular psoriasis responsive to a combination of adalimumab and acitretin.Post-approval trials of new medicines: widening use or deepening knowledge? Analysis of 10 years of etanercept.Patterns of combination therapy with alefacept for the treatment of psoriasis in Canada in the AWARE study.Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.German S3-guidelines on the treatment of psoriasis vulgaris (short version).Acitretin Use in Dermatology.S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update.Emerging drugs for psoriasis
P2860
Q34166896-74D61284-194A-4932-A481-26BCD86AEA71Q34190076-87A10C12-975A-4E95-B810-706E71AFEC2BQ34553755-7C6F3117-4644-4FA7-ABA3-791A506A5A71Q34620263-1F91A905-72E1-49E2-B89D-42F03AF99E23Q34620375-0D52D0F8-1D7B-4BBB-A9F2-47542D6E459CQ36085078-BB7F89FC-06A7-4669-A986-EC2A39BBEAD3Q37394846-AA4E27C5-1384-4AD1-BA48-439A553716D2Q37649649-AC23ED0B-D060-4336-90DA-8EBBDCCE47CCQ37724124-4BDA5C21-322B-4EBA-8FDD-8F6DA2A82507Q37776735-5EE778D4-459D-4850-8107-1621FBC506ACQ38017725-0FBF7469-AA92-4E3F-A638-0840D606F813Q38074846-271029E3-05BA-4464-9668-C4916D827446Q38084325-AFD72AE4-45B7-4F3D-8F2F-BCCEA8C51B87Q38153077-9AF947BF-6154-4576-86E2-2406F3CECD79Q38155648-D726FBF8-D108-43FE-9DD9-2761B6EAE888Q38193889-FCE5B963-E118-469B-96F6-5E83BA6AAF50Q38375060-08AC476A-0438-450B-ACE4-C9DD96DF552CQ38922128-AA2EBAB0-32E8-4DAE-B246-5759A8B918E4Q39180810-D85BF78A-B368-4654-AD2F-40D34CC716B8Q39297511-81AD1C03-C4ED-4E33-BFDD-FC93FED2DC2CQ40045451-2052583A-8ACB-4DF4-B487-0AF632A95C53Q40060986-4CA71893-CEE5-407F-A15E-1C24D1D10307Q40283992-FBD1C920-AB0B-4775-9989-F184E3476F5BQ43408664-BA28A735-FA1A-40C6-8A0A-AEF4E059F9FDQ44432805-702C643A-B06F-4302-A85C-3791157D82FCQ44566796-5916CCF6-F4D6-4109-86EA-8F0B97D01E4BQ44669251-A7BA831C-2973-4737-A042-D16C43CF51A7Q47260366-329DC0BF-60A0-4593-A37E-C7AC941DE660Q48480123-66C034C8-3C3A-4278-911D-0EB1AA2DD45CQ49793746-42365A61-5199-4B95-95B9-8B80A651E0A6Q52888818-93C41D44-44A8-469E-8A57-FD8CE38807B0Q57244448-379BB0CE-E7B7-4B07-9EEC-E03F4C35D3E4
P2860
Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Combining etanercept and acitr ...... estigator-blinded pilot trial.
@en
Combining etanercept and acitr ...... estigator-blinded pilot trial.
@nl
type
label
Combining etanercept and acitr ...... estigator-blinded pilot trial.
@en
Combining etanercept and acitr ...... estigator-blinded pilot trial.
@nl
prefLabel
Combining etanercept and acitr ...... estigator-blinded pilot trial.
@en
Combining etanercept and acitr ...... estigator-blinded pilot trial.
@nl
P2093
P2860
P1476
Combining etanercept and acitr ...... estigator-blinded pilot trial.
@en
P2093
G Girolomoni
M Del Giglio
P2860
P304
P356
10.1111/J.1365-2133.2008.08564.X
P407
P577
2008-04-10T00:00:00Z